CONDENSED CONSOLIDATED INTERIM

FINANCIAL STATEMENTS

March 31, 2023

(unaudited)

Notice to Reader:

As required by National Instrument 51-102, Part 4, subsection 4.3(3)(a), readers are advised that the Company's

independent auditors have not performed a review of the March 31, 2022 condensed consolidated interim financial

statements.

Q1 2023

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION

(Stated in thousands of Canadian dollars) (unaudited)

As at

Note

March 31, 2023

December 31, 2022

$

$

Assets

Current assets

Cash and cash equivalents

19,087

21,469

Restricted cash

7b

846

846

Trade and other receivables

8,273

12,976

Inventories

4

23,479

22,029

Prepaid expenses and deposits

1,139

1,016

52,701

58,459

Other receivables

39

39

Deferred tax assets

1,203

1,082

Property, plant and equipment

5

7,351

7,335

Intangible assets

6

6,748

7,175

Goodwill

3,700

3,703

Total assets

71,742

77,793

Liabilities

Current liabilities

Trade and other payables

8,811

10,862

Income taxes payable

318

94

Customer deposits

4,520

4,572

Provisions

523

493

Current lease liabilities

1,140

1,113

Borrowings

7

-

2,265

15,312

19,399

Lease liabilities

4,428

4,113

Borrowings

7

-

2,252

Total liabilities

19,425

26,079

Shareholders' equity

Share capital

60,265

60,135

Contributed surplus

5,710

5,758

Accumulated other comprehensive income

9,870

9,877

Accumulated deficit

(23,528)

(24,056)

Total shareholders' equity

52,317

51,714

Total liabilities and shareholders' equity

71,742

77,793

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Page 2

TSX:MCB

www.mccoyglobal.com

Q1 2023

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

(LOSS)

(Stated in thousands of Canadian dollars, except per share amounts) (unaudited)

For the three months ended March 31

2023

2022

$

$

Revenue

16,864

8,891

Cost of sales

12,036

6,199

Gross profit

4,828

2,692

General and administration

2,336

1,595

Sales and marketing

461

352

Product development and support

903

596

Finance charges, net

7

355

176

Other losses (gains), net

44

(201)

4,099

2,518

Earnings before income taxes

729

174

Income tax expense (recovery)

Current

325

-

Deferred

-

(124)

201

-

Net earnings

528

174

Other comprehensive loss

Translation loss from foreign operations

(7)

(570)

Comprehensive income (loss)

521

(396)

Net earnings per share

Basic from net earnings

0.02

0.01

Diluted from net earnings

0.02

0.01

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Page 3

TSX:MCB

www.mccoyglobal.com

Q1 2023

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY

(Stated in thousands of Canadian dollars, except per share amounts) (unaudited)

Issued capital

Accumulated

other

Number of

Contributed

comprehensive

Accumulated

shares

Share capital

surplus

income

deficit

Total equity

#

$

$

$

$

$

January 1, 2022

28,224,989

59,993

5,682

7,154

(32,819)

40,010

Net earnings

-

-

-

-

174

174

Translation loss on

foreign operations

-

-

-

(570)

-

(570)

Employee share-based

compensation

-

-

1

-

-

1

Issuance of common shares

under stock option plan

20,000

22

(9)

-

-

13

Issuance of common shares

under restricted share plan

7,500

5

-

-

-

5

March 31, 2022

28,252,489

60,020

5,674

6,584

(32,645)

39,633

January 1, 2023

28,391,789

60,135

5,758

9,877

(24,056)

51,714

Net earnings

-

-

-

-

528

528

Translation loss on

foreign operations

-

-

-

(7)

-

(7)

Employee share-based

compensation

-

-

4

-

-

4

Issuance of common shares

under stock option plan

120,000

130

(52)

-

-

78

March 31, 2023

28,511,789

60,265

5,710

9,870

(23,528)

52,317

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Page 4

TSX:MCB

www.mccoyglobal.com

Q1 2023

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(Stated in thousands of Canadian dollars) (unaudited)

For the three months ended March 31

2023

2022

Cash generated from (used in)

$

$

Operating activities

Net earnings

528

174

Adjustments for:

Depreciation of property, plant and equipment

450

596

Amortization of intangible assets

6

420

200

Finance charges, net

355

176

Share-based compensation expense

427

254

Income tax expense

201

-

Changes in non-cash working capital balances

8

998

(1,530)

Finance costs paid

(393)

(165)

Income taxes paid

(98)

-

Changes in restructuring and facility remediation provisions

(7)

(9)

Gain on disposal of property, plant and equipment

-

(269)

Net cash generated from (used in) operating activities

2,881

(573)

Investing activities

Purchases of property, plant and equipment

5

(471)

(259)

Proceeds from sale of property, plant and equipment

-

351

Additions to intangible assets

6

-

(358)

Net cash used in investing activities

(471)

(266)

Financing activities

Repayments of borrowings

7

(4,553)

-

Principal elements of lease payments

(284)

(105)

Proceeds from issuance of common shares under stock option plan

78

13

Proceeds from issuance of common shares under restricted share plan

-

5

Changes in restricted cash

7

-

110

Net cash (used in) generated from financing activities

(4,759)

23

Effect of exchange rate changes on cash and cash equivalents

(33)

(143)

Decrease in cash and cash equivalents

(2,382)

(959)

Cash and cash equivalents - beginning of the period

21,469

11,139

Cash and cash equivalents - end of the period

19,087

10,180

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Page 5

TSX:MCB

www.mccoyglobal.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

McCoy Global Inc. published this content on 12 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2023 11:16:10 UTC.